Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Amgen Ventures

WebsitecbCrunchbase
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
Investment stages
  • Series A
  • Series B
Industries
  • Pharmaceuticals
  • Drugs
  • HealthCare
  • Digital Health
  • Health Tech
About
AmgenBD is a biotech company specializing in innovative therapies for cancer, cardiovascular diseases, and inflammatory conditions through biologics and biosimilars.
Min check size
$500K
Max check size
$2M
Fund size
NPS

Investment Thesis

Amgen Focuses on investing in innovative biotechnology and pharmaceutical companies that align with Amgen’s strategic interests and advance medical science.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp